Logo image of WINT

WINDTREE THERAPEUTICS INC (WINT) Stock Fundamental Analysis

NASDAQ:WINT - Nasdaq - US97382D6004 - Common Stock - Currency: USD

0.7875  -0.03 (-3.96%)

After market: 0.8 +0.01 (+1.59%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to WINT. WINT was compared to 561 industry peers in the Biotechnology industry. Both the profitability and financial health of WINT have multiple concerns. WINT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

WINT had negative earnings in the past year.
In the past year WINT has reported a negative cash flow from operations.
In the past 5 years WINT always reported negative net income.
In the past 5 years WINT always reported negative operating cash flow.
WINT Yearly Net Income VS EBIT VS OCF VS FCFWINT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20M -40M -60M

1.2 Ratios

With a decent Return On Assets value of -35.17%, WINT is doing good in the industry, outperforming 60.25% of the companies in the same industry.
WINT's Return On Equity of -163.47% is on the low side compared to the rest of the industry. WINT is outperformed by 65.60% of its industry peers.
Industry RankSector Rank
ROA -35.17%
ROE -163.47%
ROIC N/A
ROA(3y)-85.45%
ROA(5y)-61.66%
ROE(3y)-383.83%
ROE(5y)-246.99%
ROIC(3y)N/A
ROIC(5y)N/A
WINT Yearly ROA, ROE, ROICWINT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500

1.3 Margins

WINT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WINT Yearly Profit, Operating, Gross MarginsWINT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2K -4K -6K -8K -10K

More info and screens

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, WINT has more shares outstanding
WINT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for WINT is higher compared to a year ago.
WINT Yearly Shares OutstandingWINT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20K 40K 60K 80K 100K
WINT Yearly Total Debt VS Total AssetsWINT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -42.14, we must say that WINT is in the distress zone and has some risk of bankruptcy.
WINT has a Altman-Z score of -42.14. This is amonst the worse of the industry: WINT underperforms 94.12% of its industry peers.
A Debt/Equity ratio of 0.12 indicates that WINT is not too dependend on debt financing.
WINT has a Debt to Equity ratio of 0.12. This is in the lower half of the industry: WINT underperforms 66.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z -42.14
ROIC/WACCN/A
WACCN/A
WINT Yearly LT Debt VS Equity VS FCFWINT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M

2.3 Liquidity

A Current Ratio of 0.27 indicates that WINT may have some problems paying its short term obligations.
With a Current ratio value of 0.27, WINT is not doing good in the industry: 95.54% of the companies in the same industry are doing better.
A Quick Ratio of 0.27 indicates that WINT may have some problems paying its short term obligations.
WINT's Quick ratio of 0.27 is on the low side compared to the rest of the industry. WINT is outperformed by 95.19% of its industry peers.
Industry RankSector Rank
Current Ratio 0.27
Quick Ratio 0.27
WINT Yearly Current Assets VS Current LiabilitesWINT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 98.29% over the past year.
EPS 1Y (TTM)98.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-544.19%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

WINT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.49% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y84.67%
EPS Next 2Y41.23%
EPS Next 3Y25.96%
EPS Next 5Y14.49%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
WINT Yearly Revenue VS EstimatesWINT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2022 2030 2031 50M 100M 150M 200M
WINT Yearly EPS VS EstimatesWINT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -200K -400K -600K -800K -1M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for WINT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for WINT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WINT Price Earnings VS Forward Price EarningsWINT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WINT Per share dataWINT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -100 -200 -300

4.3 Compensation for Growth

WINT's earnings are expected to grow with 25.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.23%
EPS Next 3Y25.96%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for WINT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WINDTREE THERAPEUTICS INC

NASDAQ:WINT (5/21/2025, 5:20:02 PM)

After market: 0.8 +0.01 (+1.59%)

0.7875

-0.03 (-3.96%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)05-13 2025-05-13/amc
Earnings (Next)08-18 2025-08-18/amc
Inst Owners0.89%
Inst Owner Change-85.57%
Ins Owners0.05%
Ins Owner Change0%
Market Cap2.87M
Analysts43.33
Price Target180.54 (22825.71%)
Short Float %1.39%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-146.03%
Min EPS beat(2)-152.79%
Max EPS beat(2)-139.27%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2428.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2428.07%
EPS NY rev (1m)0%
EPS NY rev (3m)-2426.47%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.44
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-400
EYN/A
EPS(NY)-2.2
Fwd EYN/A
FCF(TTM)-4.19
FCFYN/A
OCF(TTM)-4.19
OCFYN/A
SpS0
BVpS1.79
TBVpS-5.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -35.17%
ROE -163.47%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-85.45%
ROA(5y)-61.66%
ROE(3y)-383.83%
ROE(5y)-246.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 13.64%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.27
Quick Ratio 0.27
Altman-Z -42.14
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)55.35%
Cap/Depr(5y)88.07%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-544.19%
EPS Next Y84.67%
EPS Next 2Y41.23%
EPS Next 3Y25.96%
EPS Next 5Y14.49%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-59.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y27.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y27.23%
OCF growth 3YN/A
OCF growth 5YN/A